Harvard Update in Clinical Cardiology 2024 (Videos + Slides)

2024 Update in Clinical Cardiology: October 16-18, 2024

COURSE OVERVIEW

Update in Clinical Cardiology provides comprehensive updates for state-of-the-art care and guidance to incorporate them into daily practice to optimize patient outcomes. Coverage includes:

• Coronary Artery Disease
• Diabetes and Obesity
• Valvular Heart Disease
• Cardiac Biomarkers
• Heart Failure (reduced and preserved ejection fraction)
• Pulmonary Hypertension
• Cardiomyopathies
• Dyslipidemia
• Hypertension
• Atrial Fibrillation
• Supraventricular Tachycardia
• Ventricular Arrhythmias
• Thoracic Aortic Disease
• Pericarditis
• Peripheral Arterial Disease
• Renal Artery Stenosis
• Pulmonary Embolism and Venous Thromboembolism
• Cardio-oncology
• Adult Congenital Heart Disease
• Cardiac Critical Care
• Ischemia with Non-Obstructive Coronary Arteries (INOCA)
• Spontaneous Coronary Artery Dissection (SCAD)
• Heart Disease in Pregnancy
• Sports Cardiology
• Endocarditis

The faculty is assembled from the best clinician-educators at Harvard Medical School and Massachusetts General Hospital and is designed to deliver the highest quality educational experience:

• Teaching practical, effective clinical reasoning and approaches that enable you to practice state-of-the-art clinical cardiology
• Allowing ample time for participants to interact with faculty and to pose and get answers to your specific questions, including Q&A sessions and case-based panel discussions
• Providing the latest information in an engaging manner and clinically usable context so that you have knowledge you can “take home” and immediately apply to patient care

2024 PROGRAM HIGHLIGHTS

• Management of obesity and diabetes for improved cardiovascular health outcomes
• Use of GLP-1 agonists and SGLT2-inhibitors
• Thoracic aortic disease Guideline Writing Committee chair, Dr. Eric M. Isselbacher, presents and answers your questions about the new guidelines for diagnosis and treatment
• New clinical trials: data findings, updates, and implications for daily practice
• Novel transcatheter and structural treatment options: important updates for the management of valvular disease
• Optimized approaches to heart failure and cardiomyopathies, including hypertrophic cardiomyopathy and cardiac amyloidosis
• Advances in electrical devices and mechanical support
• Complex coronary artery disease management in the cath lab with novel diagnostic and revascularization techniques
• Artificial intelligence (AI) and cardiovascular medicine